Overview

A Study of 1592U89 and Ethanol When Given Together to HIV-Infected Patients

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to see how the body processes 1592U89 and ethanol (pure grain alcohol) when they are given together.
Phase:
Phase 1
Details
Lead Sponsor:
Glaxo Wellcome
Treatments:
Abacavir
Ethanol